Results 271 to 280 of about 131,254 (306)
Some of the next articles are maybe not open access.
Development of chimeric antigen receptors for multiple myeloma
Biochemical Society Transactions, 2016Multiple myeloma (MM) is a haematologic malignancy characterized by the expansion of monoclonal plasma cells in the bone marrow. It is associated with serum or urine monoclonal protein and organ damage including renal failure, anaemia, hypercalcaemia and bone lesions. Despite recent improvements MM still remains an incurable disease.
Carolina, MartÃnez-Cingolani +1 more
openaire +2 more sources
Are All Chimeric Antigen Receptors Created Equal?
Journal of Clinical Oncology, 2015In the report accompanying this article, Kochenderfer et al discuss the efficacy of autologous T cells expressing a CD19-specific chimeric antigen receptor (CAR) in patients with relapsed diffuse large B-cell lymphoma. Although previous reports have demonstrated significant antitumor activity in low-grade B-cell malignancies and B-cell acute ...
Jae H, Park, Renier J, Brentjens
openaire +2 more sources
Chasing Cancer with Chimeric Antigen Receptor Therapy
Immunotherapy, 2012Many attempts to use genetically modified T cells to halt tumor progression have been met with disappointment and significant challenges in the successful application within human patients. Porter et al., however, describe the use of genetically modified lymphocytes bearing a chimeric antigen receptor that bypasses many of the common limitations of ...
Christina D, Pham, Duane A, Mitchell
openaire +2 more sources
Chimeric antigen receptor therapy in hematologic malignancies
JAAPAABSTRACT Chimeric antigen receptor (CAR) T-cell therapy has led to significant advances in the treatment of blood cancers such as leukemia, lymphoma, and multiple myeloma, and now shows promise for solid tumors. This type of immunotherapy can achieve high response rates in patients with hematologic malignancies, but carries serious adverse ...
Elizabeth, Brownlee +2 more
openaire +2 more sources
Technologies for chimeric antigen receptor transgene delivery
Trends in Molecular MedicineEx vivo chimeric antigen receptor (CAR) T cell therapy has achieved clinical success in hematological malignancies; yet, viral transduction risks insertional mutagenesis. Developing safe and efficient nonviral approaches for the genetic engineering of T cells and other immune cells is the key to next-generation immunotherapy for cancer and noncancerous
Yudian Xiao +6 more
openaire +2 more sources
A closer look at chimeric antigen receptor specificity
Cytotherapy, 2014The success of chimeric antigen receptor (CAR)expressing T cells as therapy for refractory hematologic malignancies (1) has spurred ongoing efforts to extend their application toward other difficult-totreat tumors. High-grade gliomas, for example, are prime candidates.
openaire +2 more sources
Chimeric antigen receptor Treg therapy in transplantation
Trends in ImmunologyIn the quest for more precise and effective organ transplantation therapies, chimeric antigen receptor (CAR) regulatory T cell (Treg) therapies represent a potential cutting-edge advance. This review comprehensively analyses CAR Tregs and how they may address important drawbacks of polyclonal Tregs and conventional immunosuppressants.
Siawosh K, Eskandari +2 more
openaire +2 more sources
Asian Medical Journal and Alternative Medicine, 2018
Manop Pitukpakorn, Somchai Bovornkitti
openaire +1 more source
Manop Pitukpakorn, Somchai Bovornkitti
openaire +1 more source